Harvard Men's Health Watch

Active surveillance: An option for low-risk prostate cancer

After prostate cancer diagnosis, immediate treatment is not the only option. Some men with low-risk cancers can choose to monitor the cancer very closely and treat when the disease progresses. This allows a man to delay or avoid the risks of treatment.

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In